G2GBio Inc (456160)

Currency in KRW
61,200
-1,600(-2.55%)
Closed·
456160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
59,50064,100
52 wk Range
27,567200,500
Key Statistics
Bid/Ask
61,200.00 / 61,300.00
Prev. Close
62,800
Open
62,400
Day's Range
59,500-64,100
52 wk Range
27,567-200,500
Volume
185.03K
Average Volume (3m)
593.96K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
456160 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

456160 Income Statement

Compare 456160 to Peers and Sector

Metrics to compare
456160
Peers
Sector
Relationship
P/E Ratio
0.0x−7.6x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x8.2x3.2x
Upside (Analyst Target)
0.0%13.2%55.3%
Fair Value Upside
Unlock8.7%9.7%Unlock

G2GBIO Inc., a clinical-stage biotech company, provides pharmaceutical products. The company’s pipeline products include GB-5001, GB-5001A, and GB-5112 for the treatment of Alzheimer’s disease; GB-6002, an opioid drug that is used for post-operative pain treatment; GB-7001 for type-2 diabetes treatments; GB-5313 for the treatment of Osteoarthritis; GB-7101 and GB-7103 for the treatment of prostate cancer; GB-6201 and GB-6203 for androgenetic alopecia treatments; and GH-001 for the treatment of Hepatitis B. It also develops GB-2001 for animal castration; and GB-2006, an animal postoperative pain relief drug, which is in clinical trial stage. The company was founded in 2017 and is headquartered in Cheongju-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
468.10K2.83%29.40B
Other Institutional Investors
2.00M12.10%125.74B
Public Companies & Retail Investors
14.08M85.07%883.91B
Total
16.55M100.00%1.04T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Atinum Growth Fund 20233.38%558,53735,076,124
The Vanguard Group, Inc.2.64%437,55427,478,391

People Also Watch

134,500
476830
-3.03%
150,300
141080
-7.22%
1,095,000
267260
-4.53%
61,000
347850
-1.77%
366,500
196170
+2.52%

FAQ

What Is the G2GBio (456160) Stock Price Today?

The G2GBio stock price today is 61,200 KRW.

What Stock Exchange Does G2GBio Trade On?

G2GBio is listed and trades on the KOSDAQ.

What Is the Stock Symbol for G2GBio?

The stock symbol for G2GBio is "456160."

What Is the G2GBio Market Cap?

As of today, G2GBio market cap is 1.04T KRW.

From a Technical Analysis Perspective, Is 456160 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has G2GBio Stock Split?

G2GBio has split 1 times.

What is the current trading status of G2GBio (456160)?

As of May 19, 2026, G2GBio (456160) is trading at a price of 61,200 KRW, with a previous close of 62,800 KRW. The stock has fluctuated within a day range of 59,500 KRW to 64,100 KRW, while its 52-week range spans from 27,567 KRW to 200,500 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.